Article Type
Article
Changed
Thu, 12/15/2022 - 15:12
Display Headline
Cutaneous Adverse Reaction to Infliximab: Report of Psoriasis Developing in 3 Patients
Author(s)
Severs GA
Lawlor TH
Purcell SM
Adler DJ
Thompson R

Article PDF
080030231.pdf
Author and Disclosure Information

Severs GA, Lawlor TH, Purcell SM, Adler DJ, Thompson R

Issue
Cutis - 80(3)
Publications
Cutis
MDedge Dermatology
Psoriasis Collection
B-Cell Lymphoma ICYMI
Breast Cancer ICYMI
Topics
Psoriasis
Page Number
231-237
Sections
Original Research
Clinical Topics & News
Author(s)
Severs GA
Lawlor TH
Purcell SM
Adler DJ
Thompson R
Author(s)
Severs GA
Lawlor TH
Purcell SM
Adler DJ
Thompson R
Author and Disclosure Information

Severs GA, Lawlor TH, Purcell SM, Adler DJ, Thompson R

Author and Disclosure Information

Severs GA, Lawlor TH, Purcell SM, Adler DJ, Thompson R

Article PDF
080030231.pdf
Article PDF
080030231.pdf

Issue
Cutis - 80(3)
Issue
Cutis - 80(3)
Page Number
231-237
Page Number
231-237
Publications
Cutis
MDedge Dermatology
Psoriasis Collection
B-Cell Lymphoma ICYMI
Breast Cancer ICYMI
Publications
Cutis
MDedge Dermatology
Psoriasis Collection
B-Cell Lymphoma ICYMI
Breast Cancer ICYMI
Topics
Psoriasis
Article Type
Article
Display Headline
Cutaneous Adverse Reaction to Infliximab: Report of Psoriasis Developing in 3 Patients
Display Headline
Cutaneous Adverse Reaction to Infliximab: Report of Psoriasis Developing in 3 Patients
Sections
Original Research
Clinical Topics & News
Article Source

PURLs Copyright

Inside the Article

Article PDF Media